Using a 3-D multicellular simulation of spinal cord injury with live cell imaging to study the neural immune barrier to nanoparticle uptake
- 167 Downloads
Development of nanoparticle (NP) based therapies to promote regeneration in sites of central nervous system (CNS; i.e. brain and spinal cord) pathology relies critically on the availability of experimental models that offer biologically valid predictions of NP fate in vivo. However, there is a major lack of biological models that mimic the pathological complexity of target neural sites in vivo, particularly the responses of resident neural immune cells to NPs. Here, we have utilised a previously developed in vitro model of traumatic spinal cord injury (based on 3-D organotypic slice arrays) with dynamic time lapse imaging to reveal in real-time the acute cellular fate of NPs within injury foci. We demonstrate the utility of our model in revealing the well documented phenomenon of avid NP sequestration by the intrinsic immune cells of the CNS (the microglia). Such immune sequestration is a known translational barrier to the use of NP-based therapeutics for neurological injury. Accordingly, we suggest that the utility of our model in mimicking microglial sequestration behaviours offers a valuable investigative tool to evaluate strategies to overcome this cellular response within a simple and biologically relevant experimental system, whilst reducing the use of live animal neurological injury models for such studies.
Keywordsorganotypic slice culture microglia immune barrier corticosteroid dexamethasone time lapse microscopy
Unable to display preview. Download preview PDF.
- Hoff, D.; Sheikh, L.; Bhattacharya, S.; Nayar, S.; Webster, T. J. Comparison study of ferrofluid and powder iron oxide nanoparticle permeability across the blood-brain barrier. Int. J. Nanomedicine 2013, 8, 703–710.Google Scholar
- Bhaskar, S.; Tian, F. R.; Stoeger, T.; Kreyling, W.; de la Fuente, J. M.; Grazú, V; Borm, P.; Estrada, G.; Ntziachristos, V.; Razansky, D. Multifunctional nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: Perspectives on tracking and neuroimaging. Part. Fibre Toxicol. 2010, 7, 3.CrossRefGoogle Scholar
- Jenkins, S. I.; Roach, P.; Chari, D. M. Development of a nanomaterial bio-screening platform for neurological applications. Nanomedicine 2015, 11, 77–87.Google Scholar
- Sauer, U. G. Animal and non-animal experiments in nanotechnology—The results of a critical literature survey. ALTEX 2009, 26, 109–128.Google Scholar
- Cooper, J. A. Background Subtraction to Obtain Total Fluorescence per Cell, using ImageJ and Excel [Online], 2008; pp 1–8. http://www.cooperlab.wustl.edu/LabMethodsReagentsOperations/Background Subtract Total Fluor per Cell/Instructions.pdf (accessed Aug 20, 2015).Google Scholar
- Balentine, J. D.; Greene, W. B.; Bornstein, M. In vitro spinal cord trauma. Lab. Invest. 1988, 58, 93–99.Google Scholar
- Heinonen, T. Better science with human cell-based organ and tissue models. Altern. Lab. Anim. 2015, 43, 29–38.Google Scholar
- Burton, J. M.; O’Connor, P. W.; Hohol, M.; Beyene, J. Oral versus intravenous steroids for treatment of relapses in multiple sclerosis. Cochrane Database Syst. Rev. 2012, 12, CD006921.Google Scholar
- Zhou, Y.; Ling, E.-A.; Dheen, S. T. Dexamethasone suppresses monocyte chemoattractant protein-1 production via mitogen activated protein kinase phosphatase-1 dependent inhibition of Jun N-terminal kinase and p38 mitogen-activated protein kinase in activated rat microglia. J. Neurochem. 2007, 102, 667–678.CrossRefGoogle Scholar